You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Generalized Myasthenia Gravis

Showing 1 - 25 of 1,499
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Generalized Myasthenia Gravis Trial (rozanolixizumab)

Not yet recruiting
  • Generalized Myasthenia Gravis
  • (no location specified)
Nov 28, 2023

Generalized Myasthenia Gravis Trial (Zilucoplan)

Not yet recruiting
  • Generalized Myasthenia Gravis
  • (no location specified)
Sep 20, 2023

Generalized Myasthenia Gravis Trial (Rozanolixizumab)

Not yet recruiting
  • Generalized Myasthenia Gravis
  • (no location specified)
Jan 4, 2023

Generalized Myasthenia Gravis Trial (Efgartigimod IV)

Recruiting
  • Generalized Myasthenia Gravis
  • Efgartigimod IV
  • Leiden, Netherlands
  • +2 more
Jan 16, 2023

Generalized Myasthenia Gravis, gMG Trial (Ravulizumab)

Not yet recruiting
  • Generalized Myasthenia Gravis
  • gMG
  • (no location specified)
Dec 1, 2022

Myasthenia Gravis, Generalized Myasthenia, AChR Myasthenia Gravis Trial in Chicago (CNP-106, Placebo)

Not yet recruiting
  • Myasthenia Gravis
  • +3 more
  • Chicago, Illinois
    Research Site
Oct 30, 2023

Generalized Myasthenia Gravis Trial in Columbia (Whole-body Electrical Muscle Stimulation Exercise)

Active, not recruiting
  • Generalized Myasthenia Gravis
  • Whole-body Electrical Muscle Stimulation Exercise
  • Columbia, Missouri
    NextGen Precision Health Building, Clinical Translational Scienc
Sep 26, 2023

Myasthenia Gravis, Generalized Trial in China (Tocilizumab Injection)

Enrolling by invitation
  • Myasthenia Gravis, Generalized
  • Tocilizumab Injection
  • Beijing, Beijing, China
  • +5 more
Jan 27, 2023

Generalized Myasthenia Gravis Trial (zilucoplan (RA101495))

Not yet recruiting
  • Generalized Myasthenia Gravis
  • zilucoplan (RA101495)
  • (no location specified)
Aug 22, 2022

Generalized Myasthenia Gravis Trial in Spain, United States (ALXN1720, Placebo)

Recruiting
  • Generalized Myasthenia Gravis
  • ALXN1720
  • Placebo
  • Gainesville, Georgia
  • +7 more
Dec 20, 2022

Myasthenia Gravis, Generalized Trial in United States (Descartes-08)

Recruiting
  • Myasthenia Gravis, Generalized
  • Carlsbad, California
  • +8 more
Jan 27, 2023

Myasthenia Gravis, Generalized Trial in China (Tocilizumab Injectable Product)

Recruiting
  • Myasthenia Gravis, Generalized
  • Tocilizumab Injectable Product
  • Beijing, Beijing, China
  • +5 more
Sep 15, 2022

Generalized Myasthenia Gravis Trial in Phoenix (ALXN1830, Placebo)

Withdrawn
  • Generalized Myasthenia Gravis
  • Phoenix, Arizona
    Clinical Study Site
Feb 2, 2022

Myasthenia Gravis Trial in Shanghai (HBM9161 Injection (680mg), HBM9161 Drug Product (340mg))

Not yet recruiting
  • Myasthenia Gravis
  • HBM9161 Injection (680mg)
  • HBM9161 Drug Product (340mg)
  • Shanghai, Shanghai, China
    Huashan Hospital, Fudan University
Apr 12, 2022

Generalized Myasthenia Gravis Trial in Carlsbad (Batoclimab 680 mg SC weekly, Batoclimab 340 mg SC weekly, Matching Placebo SC)

Recruiting
  • Generalized Myasthenia Gravis
  • Batoclimab 680 mg SC weekly
  • +3 more
  • Carlsbad, California
  • +14 more
Jan 31, 2023

Myasthenia Gravis, Myasthenia Gravis, Juvenile Form, Myasthenia Gravis, Generalized Trial in Japan, Netherlands, United States

Active, not recruiting
Has Results
  • Myasthenia Gravis
  • +2 more
  • Los Angeles, California
  • +15 more
Aug 1, 2022

Generalized Myasthenia Gravis Trial in Worldwide (Efgartigimod IV)

Recruiting
  • Generalized Myasthenia Gravis
  • Efgartigimod IV
  • Wien, Austria
  • +12 more
Jul 19, 2022

Myasthenia Gravis, Generalized Trial in Roma (Rituximab, Placebo)

Recruiting
  • Myasthenia Gravis, Generalized
  • Roma, Italy
    Policlinico A. Gemelli IRCCS
May 25, 2023

Generalized Myasthenia Gravis, Myasthenia Gravis Trial in Worldwide (ALXN2050, Placebo)

Recruiting
  • Generalized Myasthenia Gravis
  • Myasthenia Gravis
  • Phoenix, Arizona
  • +45 more
Dec 15, 2022

Myasthenia Gravis Trial in Worldwide (Tolebrutininb, Placebo)

Recruiting
  • Myasthenia Gravis
  • Washington, District of Columbia
  • +22 more
Dec 8, 2022

Generalized Myasthenia Gravis Trial in Canada, United States (zilucoplan (RA101495), Placebo)

Completed
Has Results
  • Generalized Myasthenia Gravis
  • zilucoplan (RA101495)
  • Placebo
  • Mobile, Alabama
  • +29 more
Jul 26, 2022

Myasthenia Gravis Trial in Shanghai (HBM9161 Injection (680mg), Placebos)

Recruiting
  • Myasthenia Gravis
  • HBM9161 Injection (680mg)
  • Placebos
  • Shanghai, Shanghai, China
    Huashan Hospital, Fudan University
Dec 15, 2021

Myasthenia Gravis, Generalized Trial in China (Telitacicept, Placebo)

Not yet recruiting
  • Myasthenia Gravis, Generalized
  • Telitacicept
  • Placebo
  • Bengbu, Anhui, China
  • +50 more
Feb 12, 2023

Generalized Myasthenia Gravis Trial in Worldwide (Pozelimab + Cemdisiran, Cemdisiran, Placebo)

Recruiting
  • Generalized Myasthenia Gravis
  • Pozelimab + Cemdisiran
  • +3 more
  • Phoenix, Arizona
  • +46 more
Jan 31, 2023

Generalized Myasthenia Gravis Trial in Worldwide (Rozanolixizumab)

Active, not recruiting
  • Generalized Myasthenia Gravis
  • Orange, California
  • +68 more
Jul 18, 2022